Seeking Alpha

SBResident

SBResident
Send Message
View SBResident's Comments BY TICKER:
  • Dendreon Will Get Much Worse Before It Gets Better [View article]
    Some day there will be an investigation into this whole nightmare from Hedge Fund Managers to the Journalists. There are powers that be that do not want this type of medicine available and will do and say anything to stop it. The problem is I think they all thought DNDN would have gone bankrupt by now. When there is so much opposition to a drug, you ask yourself who has the most to loose. You think they want a little company like DNDN to come in and be the new kid on the block. No way. They will do and say anything to stop it.
    Mar 4 05:34 PM | Likes Like |Link to Comment
  • Dendreon: What's The Company Worth Per Share? [View article]
    I was hoping to hear Dendreon is closing the other two manufacturing plants and outsourcing Provenge to the company that manufactured it during the trials. This would eliminate a significant costs to the company.
    Nov 2 02:38 PM | Likes Like |Link to Comment
  • Will Dendreon Surprise The Street On October 30? [View article]
    I would like to see DNDN outsource their manufacturing process back to the company that ran the trials. It only makes sense.
    Oct 23 02:44 PM | Likes Like |Link to Comment
  • Will Dendreon Surprise The Street On October 30? [View article]
    For the upcoming release, I would love to hear from the CEO that they are also closing their other manufacturing plants and outsourcing the manufacturing back to the company who ran the trials. This will result in a significant cost savings.
    Oct 23 09:41 AM | Likes Like |Link to Comment
  • The Final Blow For Dendreon? [View article]
    Thank you Ted.
    Sep 5 03:55 PM | Likes Like |Link to Comment
  • The Final Blow For Dendreon? [View article]
    What are the advantages of MDVN's drug over Provenge?
    Sep 5 02:42 PM | 1 Like Like |Link to Comment
  • Dendreon Plunges On Restructuring News, Stock Downgraded [View article]
    Hi Ted, I am curious as to your thoughts of the latest earnings call? Personally, I see it as all positive except the drove of sales staff leaving the company. Usually, they see the writing on the wall first.

    I personally believe this CEO made some tough decisions, the right ones, and is setting up this company for sale.
    Aug 1 01:55 PM | Likes Like |Link to Comment
  • Dendreon: Tumbling Without Commercial Success [View article]
    DNDN manufacturing facilities are specifically designed to manufacture Provenge. Do you think J&J could just take it over and start processing Bayer Aspirin? Come on, think before you print something.
    Jul 12 11:17 AM | 1 Like Like |Link to Comment
  • Dendreon: Analyzing Takeover Prospects And Trading Second Quarter Earnings [View article]
    What I find most interesting with these so called FINANCIAL ANALYST is what they are telling their clients? We are very CAUTIOUS about Dendreon and we rate the stock a HOLD at the current price but we are putting a $13 price target on the stock? HELLO!!!!!!
    Jun 29 09:42 AM | Likes Like |Link to Comment
  • Dendreon: Room For Improvement [View article]
    Sir, you really think Dendreon can have another company come in and just start using their manufacturing plant? It is built and design to create Provenge. That's all it can do. It's not like J&J can come in and start manufacturing more Flintstones vitamins.
    Jun 13 02:09 PM | 1 Like Like |Link to Comment
  • ASCO Data Suggest Dendreon's Provenge Should Go First [View article]
    The DNDN saga continues on now with a major company trying to spin their own web about their products ability. Imagine a medical company trying to hide the truth from patients on what's the best way for you to stay alive? I wonder if the mainstream media will pick up on this story? The only way this will ever end is by DNDN continuing to show the selling of Provenge units is increasing every quarter and for them to finally take their foot out of their mouths and start responding to the NEGATIVE PRESS.
    If a Doctors want to ASSUME that another product works better because of what some amateur journalist has written without STATING all the facts, then I feel bad for their patients.
    Jun 6 08:27 PM | 5 Likes Like |Link to Comment
  • Dendreon Provenge: 13 Month Median Extended Survival For PSA 22.1 Or Less [View article]
    Looks like DNDN is going to take a hard hit today based on the new information from JNJ Zytiga. I cannot believe this company, with a break through in medical marvel, could actually be sunk before it gets off the ground. The hits just keep on coming.
    May 17 09:02 AM | Likes Like |Link to Comment
  • Pharma Bear Raids: Dendreon And Pozen [View article]
    Would love for the following to be picked up by the main print publications as well as Dendreon PR.

    IPCC Conference Chair Provenge Survival Advantage 10-11 Months 38 minutes ago
    <“In fact, if you look at our analysis of the patients who received a frozen product on the control arm and those who did not receive it, there was a significant survival advantage to those patients who did receive the frozen product,” said Gomella. “It made the difference between the control arm and the actual treatment arm much closer. And if you take out those patients who did not receive the frozen product on the control arm, that survival difference actually approaches 10 to 11 months.”>
    Apr 20 10:50 AM | Likes Like |Link to Comment
  • Pharma Bear Raids: Dendreon And Pozen [View article]
    I wish the major print publications would run with this article as well as Dendreon's PR department.

    http://bit.ly/J2Lb8W
    Apr 20 10:22 AM | Likes Like |Link to Comment
  • Pharma Bear Raids: Dendreon And Pozen [View article]
    I wish the following news article would be picked up by all the major Print publications. I would also like to see Dendreon run with this article.

    http://bit.ly/J2Lb8W
    Apr 20 10:22 AM | Likes Like |Link to Comment
More on DNDN by SBResident
COMMENTS STATS
46 Comments
112 Likes